• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌体外模型中卵巢癌腹水对细胞侵袭、增殖、球体形成及基因表达的特征分析

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

作者信息

Puiffe Marie-Line, Le Page Cécile, Filali-Mouhim Abdelali, Zietarska Magdalena, Ouellet Véronique, Tonin Patricia N, Chevrette Mario, Provencher Diane M, Mes-Masson Anne-Marie

机构信息

Centre de recherche du Centre hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montreal, Quebec, Canada.

出版信息

Neoplasia. 2007 Oct;9(10):820-9. doi: 10.1593/neo.07472.

DOI:10.1593/neo.07472
PMID:17971902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2040209/
Abstract

At least one third of all cases of epithelial ovarian cancer are associated with the production of ascites, although its effect on tumor cell microenvironment remains poorly understood. This study addresses the effect of the heterologous acellular fraction of ovarian cancer-derived ascites on a cell line (OV-90) derived from the chemotherapy-naïve ovarian cancer patient. Ascites were assayed for their effect on cell invasion, growth, and spheroid formation. When compared to either no serum or 5% serum, ascites fell into one of two categories: stimulatory or inhibitory. RNA from OV-90 cells exposed to selected ascites were arrayed on an Affymetrix HG-U133A GeneChip. A supervised analysis identified a number of differentially expressed genes and quantitative polymerase chain reaction validation based on OV-90 cells exposed to 54 independent ascites demonstrated that stimulatory ascites affected the expression of ISGF3G, TRIB1, MKP1, RGS4, PLEC1, and MOSPD1 genes. In addition, TRIB1 expression was shown to independently correlate with prognosis when its expression was ascertained in an independent set of primary cultures established from ovarian ascites. The data support the validity of the strategy to uncover molecular events that are associated with tumor cell behavior and highlight the impact of ascites on the cellular and molecular parameters of ovarian cancer.

摘要

至少三分之一的上皮性卵巢癌病例与腹水产生有关,尽管其对肿瘤细胞微环境的影响仍知之甚少。本研究探讨了卵巢癌来源腹水的异源无细胞成分对来自未经化疗的卵巢癌患者的细胞系(OV-90)的影响。检测了腹水对细胞侵袭、生长和球体形成的作用。与无血清或5%血清相比,腹水分为两类:刺激性或抑制性。将暴露于选定腹水的OV-90细胞的RNA阵列于Affymetrix HG-U133A基因芯片上。一项监督分析鉴定出一些差异表达基因,基于暴露于54份独立腹水的OV-90细胞进行的定量聚合酶链反应验证表明,刺激性腹水影响ISGF3G、TRIB1、MKP1、RGS4、PLEC1和MOSPD1基因的表达。此外,当在从卵巢腹水中建立的一组独立原代培养物中确定TRIB1表达时,其表达显示与预后独立相关。这些数据支持了揭示与肿瘤细胞行为相关分子事件策略的有效性,并突出了腹水对卵巢癌细胞和分子参数的影响。

相似文献

1
Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.上皮性卵巢癌体外模型中卵巢癌腹水对细胞侵袭、增殖、球体形成及基因表达的特征分析
Neoplasia. 2007 Oct;9(10):820-9. doi: 10.1593/neo.07472.
2
Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro model.卵巢癌腹水对体外人卵巢癌细胞系迁移和基因表达的影响。
Transl Oncol. 2010 Aug 1;3(4):230-8. doi: 10.1593/tlo.10103.
3
Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.恶性腹水在体外增强了具有膜结合白细胞介素-6受体的卵巢癌细胞的迁移和侵袭特性。
Oncotarget. 2016 Dec 13;7(50):83148-83159. doi: 10.18632/oncotarget.13074.
4
Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.从上皮性卵巢腺癌患者腹水中分离和鉴定基质祖细胞。
J Biomed Sci. 2012 Feb 14;19(1):23. doi: 10.1186/1423-0127-19-23.
5
TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.转化生长因子β信号通路调节卵巢癌腹水来源球体中的上皮-间质可塑性。
Endocr Relat Cancer. 2016 Mar;23(3):147-59. doi: 10.1530/ERC-15-0383. Epub 2015 Dec 8.
6
Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.上皮性卵巢癌的遗传和临床异质性建模。
Carcinogenesis. 2011 Oct;32(10):1540-9. doi: 10.1093/carcin/bgr140. Epub 2011 Aug 22.
7
An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.mDia2/ROCK信号轴调节上皮性卵巢癌球体的侵袭性穿出。
PLoS One. 2014 Feb 28;9(2):e90371. doi: 10.1371/journal.pone.0090371. eCollection 2014.
8
Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.糖皮质激素抑制卵巢癌细胞死亡并上调半胱天冬酶抑制剂cIAP2。
Clin Cancer Res. 2005 Sep 1;11(17):6325-32. doi: 10.1158/1078-0432.CCR-05-0182.
9
Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.Aurora B 的过表达与上皮性卵巢癌患者的不良预后相关。
Virchows Arch. 2009 Nov;455(5):431-40. doi: 10.1007/s00428-009-0838-3. Epub 2009 Oct 17.
10
BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.BMP 信号通过 AKT 激酶激活控制腹水来源的人上皮性卵巢癌球体的恶性潜能。
Clin Exp Metastasis. 2012 Apr;29(4):293-313. doi: 10.1007/s10585-011-9451-3. Epub 2012 Jan 17.

引用本文的文献

1
Underestimated role of macromolecular crowding in bioengineered models of health and diseases.大分子拥挤效应在生物工程健康与疾病模型中被低估的作用。
Mater Today Bio. 2025 Apr 17;32:101772. doi: 10.1016/j.mtbio.2025.101772. eCollection 2025 Jun.
2
Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis.通过球体和类器官分析探索上皮性卵巢癌中的癌症休眠信号机制
Cells. 2025 Jan 17;14(2):133. doi: 10.3390/cells14020133.
3
TRIB1 facilitates the proliferation and migration of ovarian cancer cells by inducing EMT progression.TRIB1通过诱导上皮-间质转化进程促进卵巢癌细胞的增殖和迁移。
Histol Histopathol. 2025 Sep;40(9):1447-1455. doi: 10.14670/HH-18-868. Epub 2024 Dec 31.
4
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer.腹腔 TGF-β1 水平升高与腹水诱导的 NK 细胞功能障碍和高级别上皮性卵巢癌患者生存时间缩短有关。
Front Immunol. 2024 Sep 23;15:1448041. doi: 10.3389/fimmu.2024.1448041. eCollection 2024.
5
Deciphering MOSPD1's impact on breast cancer progression and therapeutic response.解析 MOSPD1 对乳腺癌进展和治疗反应的影响。
Biol Direct. 2024 Oct 5;19(1):88. doi: 10.1186/s13062-024-00531-9.
6
Plectin: Dual Participation in Tumor Progression.粘连蛋白:双重参与肿瘤进展。
Biomolecules. 2024 Aug 24;14(9):1050. doi: 10.3390/biom14091050.
7
Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.治疗诱导的剪接体成分分泌介导卵巢癌细胞间的促生存串扰。
Nat Commun. 2024 Jun 19;15(1):5237. doi: 10.1038/s41467-024-49512-6.
8
Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase.恶性腹水上清液部分通过上调天冬酰胺合成酶来增强胃癌细胞的增殖。
Oncol Lett. 2023 Aug 10;26(4):418. doi: 10.3892/ol.2023.14005. eCollection 2023 Oct.
9
TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response.TRIB1 通过拮抗 NRF2 介导的抗氧化反应来调节肝脏再生。
Cell Death Dis. 2023 Jun 24;14(6):372. doi: 10.1038/s41419-023-05896-9.
10
The Development of a Three-Dimensional Platform for Patient-Derived Ovarian Cancer Tissue Models: A Systematic Literature Review.用于患者来源的卵巢癌组织模型的三维平台的开发:一项系统文献综述
Cancers (Basel). 2022 Nov 16;14(22):5628. doi: 10.3390/cancers14225628.

本文引用的文献

1
Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).用于上皮性卵巢癌(EOC)研究的三维体外模型的分子描述。
Mol Carcinog. 2007 Oct;46(10):872-85. doi: 10.1002/mc.20315.
2
Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.晚期卵巢癌患者的腹腔内化疗:护理证据与标准综述
Gynecol Oncol. 2007 Jun;105(3):747-56. doi: 10.1016/j.ygyno.2007.02.015. Epub 2007 Mar 21.
3
SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.富含半胱氨酸的酸性分泌蛋白(SPARC)抑制溶血磷脂酸(LPA)介导的间皮细胞与卵巢癌细胞的相互作用。
Neoplasia. 2007 Jan;9(1):23-35. doi: 10.1593/neo.06658.
4
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?在晚期卵巢癌中,腹腔内化疗应被视为标准的一线治疗方法吗?
Crit Rev Oncol Hematol. 2007 May;62(2):137-47. doi: 10.1016/j.critrevonc.2006.11.009. Epub 2006 Dec 26.
5
Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.人卵巢癌腹水含有纤维蛋白不完全降解的可溶性产物混合物,这些产物共同具有抗血管生成特性。
Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1536-44. doi: 10.1111/j.1525-1438.2006.00624.x.
6
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.顺铂和紫杉醇腹腔内给药治疗卵巢癌
N Engl J Med. 2006 Jan 5;354(1):34-43. doi: 10.1056/NEJMoa052985.
7
Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line.头颈癌细胞系紫杉醇耐药克隆中的差异基因表达
Eur Arch Otorhinolaryngol. 2006 Feb;263(2):127-34. doi: 10.1007/s00405-005-0936-z. Epub 2005 Dec 28.
8
Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.基质金属蛋白酶-7通过激活表皮生长因子受体介导的丝裂原活化蛋白激酶/细胞外信号调节激酶信号转导途径参与胰腺癌细胞的侵袭。
J Clin Pathol. 2005 Dec;58(12):1242-8. doi: 10.1136/jcp.2004.025338.
9
Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.腹水可诱导卵巢癌中α6β1整合素和尿激酶型纤溶酶原激活物受体表达及相关功能的调节。
Br J Cancer. 2005 Apr 25;92(8):1475-85. doi: 10.1038/sj.bjc.6602495.
10
Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling.鉴定和表征G蛋白信号调节因子4(RGS4)作为一种新的管生成抑制剂:RGS4抑制丝裂原活化蛋白激酶和血管内皮生长因子信号传导。
Mol Biol Cell. 2005 Feb;16(2):609-25. doi: 10.1091/mbc.e04-06-0479. Epub 2004 Nov 17.